June 22, 2017

Around the nation: Baltimore's supply of naloxone running low as opioid overdoses surge

Daily Briefing
  • Maryland: The Baltimore City Health Department's supply of the overdose-reversal drug naloxone—meant to last through May 2018—could run out by the end of July if the department doesn't begin rationing the doses, according to a report released by the department. Baltimore City Health Commissioner Leana Wen said the city doesn't have enough of the drug to treat all the cases of fentanyl, heroin, and other opioid-related overdoses occurring in Baltimore. Wen said she is asking the state to allocate more funding to replenish the city's naloxone stockpile (Bean, Becker's Hospital Review, 6/20)

  • Michigan: Gov. Rick Snyder (R) is expected to sign recently passed legislation that would make Michigan the 26th state to criminalize female genital mutilation, David Eggert writes for the Associated Press. According Eggert, federal law already makes female genital mutilation a crime punishable by up to five years in prison. Under the bill, anyone who knowingly aids in the act of female genital mutilation could face up to 15 years imprisonment (Eggert, AP/Sacramento Bee, 6/20).

  • Pennsylvania: J.C. Blair Health System in Huntingdon, Pennsylvania, has named Adam Dimm to be its CEO. Dimm, who presently works as the system's COO, previously worked as director of strategic management services for PinnacleHealth (Vaidya, Becker's Hospital Review, 6/20).

Learn the 8 steps for deploying clinical pharmacists in ambulatory care

As the number of medications rises, so does the opportunity for medication errors, such as incorrect dosages, drug interactions, and serious side effects. By some estimates, the U.S. spends as much money correcting these medications problems as we do on the drugs themselves.

Check out our infographic to learn eight steps for how to deploy clinical pharmacists in outpatient clinics.

Download the Infographic

X
Cookies help us improve your website experience. By using our website, you agree to our use of cookies.